vNN Web Server for ADMET Predictions

In drug development, early assessments of pharmacokinetic and toxic properties are important stepping stones to avoid costly and unnecessary failures. Considerable progress has recently been made in the development of computer-based (in silico) models to estimate such properties. Nonetheless, such models can be further improved in terms of their ability to make predictions more rapidly, easily, and with greater reliability. To address this issue, we have used our vNN method to develop 15 absorption, distribution, metabolism, excretion, and toxicity (ADMET) prediction models. These models quickly assess some of the most important properties of potential drug candidates, including their cytotoxicity, mutagenicity, cardiotoxicity, drug-drug interactions, microsomal stability, and likelihood of causing drug-induced liver injury. Here we summarize the ability of each of these models to predict such properties and discuss their overall performance. All of these ADMET models are publically available on our website (https://vnnadmet.bhsai.org/), which also offers the capability of using the vNN method to customize and build new models.

[1]  Tudor I. Oprea,et al.  A novel approach for predicting P-glycoprotein (ABCB1) inhibition using molecular interaction fields. , 2011, Journal of medicinal chemistry.

[2]  Graham Dunn,et al.  Clinical Biostatistics: An Introduction to Evidence-Based Medicine , 1995 .

[3]  Lei Chen,et al.  ADME evaluation in drug discovery. 10. Predictions of P-glycoprotein inhibitors using recursive partitioning and naive Bayesian classification techniques. , 2011, Molecular pharmaceutics.

[4]  Woody Sherman,et al.  Analysis and comparison of 2D fingerprints: insights into database screening performance using eight fingerprint methods , 2010, J. Cheminformatics.

[5]  S. Pieczenik,et al.  Mitochondrial dysfunction and molecular pathways of disease. , 2007, Experimental and molecular pathology.

[6]  E. Hansson,et al.  Astrocyte–endothelial interactions at the blood–brain barrier , 2006, Nature Reviews Neuroscience.

[7]  Youyong Li,et al.  ADMET evaluation in drug discovery. 12. Development of binary classification models for prediction of hERG potassium channel blockage. , 2012, Molecular pharmaceutics.

[8]  Chava Kimchi-Sarfaty,et al.  P-glycoprotein: from genomics to mechanism , 2003, Oncogene.

[9]  Ruifeng Liu,et al.  Locally weighted learning methods for predicting dose-dependent toxicity with application to the human maximum recommended daily dose. , 2012, Chemical research in toxicology.

[10]  B. Ames,et al.  Carcinogens are mutagens: a simple test system combining liver homogenates for activation and bacteria for detection. , 1973, Proceedings of the National Academy of Sciences of the United States of America.

[11]  Klaus-Robert Müller,et al.  Benchmark Data Set for in Silico Prediction of Ames Mutagenicity , 2009, J. Chem. Inf. Model..

[12]  Ruili Huang,et al.  Tox21Challenge to Build Predictive Models of Nuclear Receptor and Stress Response Pathways as Mediated by Exposure to Environmental Chemicals and Drugs , 2016, Front. Environ. Sci..

[13]  V. Navarro,et al.  Human drug hepatotoxicity: a contemporary clinical perspective. , 2009, Expert opinion on drug metabolism & toxicology.

[14]  P. Borst,et al.  Mammalian ABC transporters in health and disease. , 2002, Annual review of biochemistry.

[15]  Jeremy Adler,et al.  Quantifying colocalization by correlation: The Pearson correlation coefficient is superior to the Mander's overlap coefficient , 2010, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[16]  R. M. Owen,et al.  An analysis of the attrition of drug candidates from four major pharmaceutical companies , 2015, Nature Reviews Drug Discovery.

[17]  Tingjun Hou,et al.  ADME evaluation in drug discovery , 2002, Journal of molecular modeling.

[18]  J. Dearden,et al.  QSAR modeling: where have you been? Where are you going to? , 2014, Journal of medicinal chemistry.

[19]  Olivier Michielin,et al.  SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules , 2017, Scientific Reports.

[20]  Chin Yee Liew,et al.  Mixed learning algorithms and features ensemble in hepatotoxicity prediction , 2011, J. Comput. Aided Mol. Des..

[21]  David Rogers,et al.  Extended-Connectivity Fingerprints , 2010, J. Chem. Inf. Model..

[22]  Elisabetta Poluzzi,et al.  Organising evidence on QT prolongation and occurrence of Torsades de Pointes with non-antiarrhythmic drugs: a call for consensus , 2001, European Journal of Clinical Pharmacology.

[23]  Dan Li,et al.  ADMET evaluation in drug discovery. 13. Development of in silico prediction models for P-glycoprotein substrates. , 2014, Molecular pharmaceutics.

[24]  Nigel Greene,et al.  Developing structure-activity relationships for the prediction of hepatotoxicity. , 2010, Chemical research in toxicology.

[25]  David Weininger,et al.  SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules , 1988, J. Chem. Inf. Comput. Sci..

[26]  Yanli Wang,et al.  PubChem: a public information system for analyzing bioactivities of small molecules , 2009, Nucleic Acids Res..

[27]  George Papadatos,et al.  The ChEMBL bioactivity database: an update , 2013, Nucleic Acids Res..

[28]  D. Huryn,et al.  Optimization of a Higher Throughput Microsomal Stability Screening Assay for Profiling Drug Discovery Candidates , 2003, Journal of biomolecular screening.

[29]  Luhua Lai,et al.  Deep Learning for Drug-Induced Liver Injury , 2015, J. Chem. Inf. Model..

[30]  Peter V. Henstock,et al.  Cellular imaging predictions of clinical drug-induced liver injury. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[31]  Weida Tong,et al.  FDA-approved drug labeling for the study of drug-induced liver injury. , 2011, Drug discovery today.

[32]  Emilio Benfenati,et al.  Predicting persistence in the sediment compartment with a new automatic software based on the k-Nearest Neighbor (k-NN) algorithm. , 2016, Chemosphere.

[33]  Ruifeng Liu,et al.  Critically Assessing the Predictive Power of QSAR Models for Human Liver Microsomal Stability , 2015, J. Chem. Inf. Model..

[34]  Klaus R. Liedl,et al.  Qualitative prediction of blood–brain barrier permeability on a large and refined dataset , 2011, J. Comput. Aided Mol. Des..

[35]  N. Kruhlak,et al.  Estimating the safe starting dose in phase I clinical trials and no observed effect level based on QSAR modeling of the human maximum recommended daily dose. , 2004, Regulatory toxicology and pharmacology : RTP.

[36]  Robert P. Sheridan,et al.  Time-Split Cross-Validation as a Method for Estimating the Goodness of Prospective Prediction , 2013, J. Chem. Inf. Model..

[37]  Michael O. Hengartner,et al.  Mitochondria as a Target of Environmental Toxicants , 2013, Toxicological sciences : an official journal of the Society of Toxicology.

[38]  R. Naef,et al.  A Generally Applicable Computer Algorithm Based on the Group Additivity Method for the Calculation of Seven Molecular Descriptors: Heat of Combustion, LogPO/W, LogS, Refractivity, Polarizability, Toxicity and LogBB of Organic Compounds; Scope and Limits of Applicability , 2015, Molecules.

[39]  M. Sanguinetti,et al.  hERG potassium channels and cardiac arrhythmia , 2006, Nature.

[40]  Micha Rautenberg,et al.  lazar: a modular predictive toxicology framework , 2013, Front. Pharmacol..

[41]  Alexander Tropsha,et al.  Novel Variable Selection Quantitative Structure-Property Relationship Approach Based on the k-Nearest-Neighbor Principle , 2000, J. Chem. Inf. Comput. Sci..

[42]  Paul Czodrowski,et al.  hERG Me Out , 2013, J. Chem. Inf. Model..

[43]  Ruifeng Liu,et al.  Merging Applicability Domains for in Silico Assessment of Chemical Mutagenicity , 2014, J. Chem. Inf. Model..

[44]  Alexander Tropsha,et al.  Chembench: a cheminformatics workbench , 2010, Bioinform..

[45]  A. Wallqvist,et al.  Using the Variable-Nearest Neighbor Method To Identify P-Glycoprotein Substrates and Inhibitors , 2016, ACS omega.

[46]  Ruili Huang,et al.  Profiling of the Tox21 Chemical Collection for Mitochondrial Function to Identify Compounds that Acutely Decrease Mitochondrial Membrane Potential , 2014, Environmental health perspectives.

[47]  M. Murray.  Role of CYP pharmacogenetics and drug‐drug interactions in the efficacy and safety of atypical and other antipsychotic agents , 2006, The Journal of pharmacy and pharmacology.

[48]  Igor V. Tetko,et al.  Online chemical modeling environment (OCHEM): web platform for data storage, model development and publishing of chemical information , 2011, J. Comput. Aided Mol. Des..

[49]  C. Brown,et al.  Cytochromes P450: a structure-based summary of biotransformations using representative substrates. , 2008, Drug metabolism reviews.

[50]  Jie Shen,et al.  admetSAR: A Comprehensive Source and Free Tool for Assessment of Chemical ADMET Properties , 2012, J. Chem. Inf. Model..

[51]  P. Willett,et al.  Comparison of topological descriptors for similarity-based virtual screening using multiple bioactive reference structures. , 2004, Organic & biomolecular chemistry.